FDA approves first therapy for Alexander disease

• by Kathryn Wighton

• September 4, 2026

Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome

The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.

• by

• August 13, 2026

• 4 min

PET/MRI may reveal MRI-occult inflammation

In a rare anti-vimentin encephalitis case, molecular imaging detected abnormalities that declined alongside neurologic improvement following immunotherapy.

• by Andrea Surnit

• October 28, 2026

• 4 min

FDA Clears Exoskeleton for Spinal Cord Injury

Use is limited to level indoor and adjoining outdoor areas and requires supervision by a companion with specialized training.

• by Kathryn Wighton

• August 12, 2026

• 2 min